# RDF export of group: Publication
<http://ctro/data#Publication_45906> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_45906> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 45906" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasTitle> "Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add - on or lone therapy ( INTERVAL ) : a 24 week , randomised , double - blind , placebo - controlled study ." .
<http://ctro/data#Publication_45906> <http://ctro/data#hasAuthor> "Strain WD" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasPublicationYear> "2013" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasJournal> "Lancet" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasPMID> "23706759" .
<http://ctro/data#Publication_45906> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_45913> .
<http://ctro/data#Publication_45906> <http://ctro/data#hasAuthor> "Lukashevich V" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasAuthor> "Kothny W" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasAuthor> "Hoellinger MJ" .
<http://ctro/data#Publication_45906> <http://ctro/data#hasAuthor> "Pald á nius PM" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_45913> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_45913> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 45913" .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasObjectiveDescription> "We aimed to assess the feasibility of setting and achieving individualised targets over 24 weeks along with conventional HbA1c reduction using vildagliptin versus placebo ." .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasCTduration> "24 week" .
<http://ctro/data#AllocationRatio_45917> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_45917> .
<http://ctro/data#CTAnalysisApproach_45918> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasConclusionComment> "This study is the first to introduce and show the feasibility of using individualised HbA1c targets as an endpoint in any type 2 diabetes population ." .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasArm> <http://ctro/data#Arm_45937> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasPopulation> <http://ctro/data#Population_45929> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_46048> .
<http://ctro/data#EvidenceQuality_45925> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasConclusionComment> "Individualised glycaemic target levels are achievable with vildagliptin without any tolerability issues in the elderly type 2 diabetes population ." .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasArm> <http://ctro/data#Arm_45946> .
<http://ctro/data#ClinicalTrial_45913> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_46116> .
# RDF export of group: Population
<http://ctro/data#Population_45929> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_45929> <http://www.w3.org/2000/01/rdf-schema#label> "Population 45929" .
<http://ctro/data#Population_45929> <http://ctro/data#hasPrecondition> "elderly patients with type 2 diabetes using vildagliptin add - on or lone therapy" .
<http://ctro/data#Ethnicity_45931> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Country_45932> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country> .
<http://ctro/data#Population_45929> <http://ctro/data#hasMinAge> "70" .
<http://ctro/data#Gender_45936> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_45989> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_45989> <http://www.w3.org/2000/01/rdf-schema#label> "hbat" .
<http://ctro/data#Endpoint_45989> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_45991> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_45992> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_45993> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_46057> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_46057> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#Endpoint_46057> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#AggregationMethod_46059> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_46057> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_46061> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_45937> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_45937> <http://www.w3.org/2000/01/rdf-schema#label> "vil" .
<http://ctro/data#Arm_45937> <http://ctro/data#hasNumberPatientsArm> "139" .
<http://ctro/data#Arm_45937> <http://ctro/data#hasFinalNumPatientsArm> "137" .
<http://ctro/data#Arm_45937> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_45955> .
<http://ctro/data#Arm_45937> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_45994> .
<http://ctro/data#Outcome_45942> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Arm_45937> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_46062> .
<http://ctro/data#Arm_45946> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_45946> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Arm_45946> <http://ctro/data#hasNumberPatientsArm> "139" .
<http://ctro/data#Arm_45946> <http://ctro/data#hasFinalNumPatientsArm> "137" .
<http://ctro/data#Arm_45946> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_45961> .
<http://ctro/data#Arm_45946> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_46021> .
<http://ctro/data#Outcome_45951> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Arm_45946> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_46089> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_45955> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_45955> <http://www.w3.org/2000/01/rdf-schema#label> "vil" .
<http://ctro/data#Intervention_45955> <http://ctro/data#hasMedication> <http://ctro/data#Medication_45967> .
<http://ctro/data#Intervention_45955> <http://ctro/data#hasFrequency> "once or twice daily" .
<http://ctro/data#RelativeTime_45960> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_45961> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_45961> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Intervention_45961> <http://ctro/data#hasMedication> <http://ctro/data#Medication_45974> .
<http://ctro/data#RelativeTime_45966> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_45967> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_45967> <http://www.w3.org/2000/01/rdf-schema#label> "vil" .
<http://ctro/data#Medication_45967> <http://ctro/data#hasDrug> <http://ctro/data#Vildagliptin> .
<http://ctro/data#Medication_45967> <http://ctro/data#hasDoseValue> "50" .
<http://ctro/data#Medication_45967> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_45971> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_45974> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_45974> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Medication_45974> <http://ctro/data#hasDrug> <http://ctro/data#Placebo> .
<http://ctro/data#BioAndMedicalUnit_45977> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_45978> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_45994> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_45994> <http://www.w3.org/2000/01/rdf-schema#label> "hbat 1" .
<http://ctro/data#Outcome_45994> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_45989> .
<http://ctro/data#Outcome_45994> <http://ctro/data#hasNumberAffected> "72" .
<http://ctro/data#Outcome_45994> <http://ctro/data#hasPercentageAffected> "52 · 6" .
<http://ctro/data#Outcome_46021> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46021> <http://www.w3.org/2000/01/rdf-schema#label> "hbat 2" .
<http://ctro/data#Outcome_46021> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_45989> .
<http://ctro/data#Outcome_46021> <http://ctro/data#hasNumberAffected> "37" .
<http://ctro/data#Outcome_46021> <http://ctro/data#hasPercentageAffected> "27" .
<http://ctro/data#Outcome_46062> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46062> <http://www.w3.org/2000/01/rdf-schema#label> "hba 1" .
<http://ctro/data#Outcome_46062> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46057> .
<http://ctro/data#Outcome_46062> <http://ctro/data#hasBaselineValue> "7 · 9" .
<http://ctro/data#Outcome_46062> <http://ctro/data#hasChangeValue> "0 · 9" .
<http://ctro/data#Outcome_46089> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46089> <http://www.w3.org/2000/01/rdf-schema#label> "hba 2" .
<http://ctro/data#Outcome_46089> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46057> .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_46048> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_46048> <http://www.w3.org/2000/01/rdf-schema#label> "hbat" .
<http://ctro/data#DiffBetweenGroups_46048> <http://ctro/data#hasPvalueDiff> "p < 0 · 0001" .
<http://ctro/data#DiffBetweenGroups_46048> <http://ctro/data#hasConfIntervalDiff> "CI 1 · 81 - 5 · 52" .
<http://ctro/data#DiffBetweenGroups_46048> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_45994> .
<http://ctro/data#DiffBetweenGroups_46048> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_46021> .
<http://ctro/data#DiffBetweenGroups_46116> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_46116> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#DiffBetweenGroups_46116> <http://ctro/data#hasDiffGroupAbsValue> "- 0 · 6" .
<http://ctro/data#DiffBetweenGroups_46116> <http://ctro/data#hasPvalueDiff> "p < 0 · 0001" .
<http://ctro/data#DiffBetweenGroups_46116> <http://ctro/data#hasConfIntervalDiff> "98 · 8 % CI - 0 · 81 to - 0 · 33" .
<http://ctro/data#DiffBetweenGroups_46116> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_46062> .
<http://ctro/data#DiffBetweenGroups_46116> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_46089> .
# RDF export of group: EvidenceQuality